Dr. David Greeley, MD, FAAN, founder of Northwest Neurological, focuses on the details of clinical trials and what they mean for you and your family.

AFE has partnered with Athira Pharma for outreach on new clinical trials for ATH-1017, an investigational treatment for Alzheimer’s Disease. In this segment, Dr. David Greeley, MD, FAAN, founder of Northwest Neurological, focuses on the details of clinical trials and what they mean for you and your family. Northwest Neurological in Spokane, Washington provides medical services to patients with neurological concerns…

Read More

An interview with Dr. Charles Bernick, MD, MPH, a clinical professor at the University of Washington Department of Neurology who has researched Alzheimer’s Disease and treatments for 25 years.

In this segment sponsored by Athira Pharma, Suzanne speaks with  Dr. Charles Bernick, MD, MPH, a clinical professor at the University of Washington Department of Neurology who has researched Alzheimer’s Disease and treatments for 25 years. He is Director of Clinical Trials for the Memory & Brain Wellness Clinic and a co-investigator at the Alzheimer’s Disease Research Center.

Read More